Steven P. Gelone - 06 Dec 2021 Form 4 Insider Report for Nabriva Therapeutics plc

Role
President and COO, Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Issuer symbol
N/A
Transactions as of
06 Dec 2021
Net transactions value
-$66.24
Form type
4
Filing time
08 Dec 2021, 16:13:14 UTC
Previous filing
02 Dec 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability $66.24 -92 -0.03% $0.7200 366,196 06 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.